FDA Regulation of Radiation-Emitting Products
Federal law assigns the Food and Drug Administration authority over a broad category of products that emit radiation — an oversight responsibility that extends well beyond medical imaging equipment to include consumer electronics, industrial devices, and household appliances. This page explains which products fall under FDA's radiation control framework, how the regulatory mechanism operates, what compliance scenarios arise most frequently, and where jurisdictional lines separate FDA authority from that of other agencies. Understanding this framework matters because non-compliant products can expose manufacturers to product detention, mandatory recalls, and civil penalties under federal statute.
Definition and scope
FDA's authority over radiation-emitting electronic products derives from the Electronic Product Radiation Control (EPRC) provisions of the Federal Food, Drug, and Cosmetic Act (FD&C Act), originally enacted through the Radiation Control for Health and Safety Act of 1968 and later consolidated at 21 U.S.C. §§ 360hh–360ss. The statute defines an "electronic product" as any manufactured or assembled product, or component, which, when in operation, may emit electronic product radiation.
"Electronic product radiation" under the statute encompasses ionizing radiation (X-rays, gamma rays, particle emissions) and non-ionizing radiation (ultraviolet, visible light, infrared, microwave, radio frequency, and sonic, including ultrasonic, frequencies). This dual scope means products as technically dissimilar as a dental X-ray machine and a microwave oven fall within the same statutory framework.
FDA's Center for Devices and Radiological Health (CDRH) administers the program. CDRH maintains performance standards for product categories it has formally regulated, and retains authority to establish new standards for any electronic product radiation-emitting device. An overview of how CDRH fits within the broader agency structure is available at FDA Centers and Offices.
The regulatory program covers both domestically manufactured products and imported goods. Importers must demonstrate that their products comply with all applicable performance standards or obtain a variance before entry into U.S. commerce, a process administered in coordination with FDA's import operations detailed at FDA Import Regulations and Detentions.
How it works
The EPRC framework operates primarily through performance standards rather than premarket approval for most non-medical radiation-emitting products. Manufacturers must certify that their products comply with applicable performance standards before introducing them into commerce.
The core compliance mechanism involves 4 mandatory steps:
- Certification — Manufacturers must certify compliance with applicable performance standards. This certification must appear on the product label (21 C.F.R. Part 1010).
- Record keeping — Manufacturers must maintain records of testing, design, and production sufficient to demonstrate ongoing compliance. Records must be available for FDA inspection.
- Defect and noncompliance reporting — Manufacturers and assemblers must report to FDA within 5 days of discovering that a product fails to comply with an applicable standard or contains a defect that could cause injury (21 C.F.R. § 1003.10).
- Notification and remedy — When a noncompliance or defect is confirmed, manufacturers must notify distributors, dealers, and purchasers, and provide an adequate remedy, which may include repair, replacement, or refund.
This performance-standard model contrasts with the premarket approval model used for high-risk medical devices under FDA Premarket Approval (PMA). Under PMA, FDA affirmatively reviews and approves each product before market entry. Under the EPRC framework, the manufacturer self-certifies and FDA exercises post-market surveillance, inspections, and enforcement.
Where a radiation-emitting product is also a medical device — a computed tomography (CT) scanner, for example — both the EPRC performance standards and the medical device regulatory pathway apply concurrently. CDRH has published specific performance standards for diagnostic X-ray systems at 21 C.F.R. Part 1020, covering equipment including fluoroscopic systems, CT systems, and radiographic systems used in clinical settings.
Common scenarios
Laser products represent one of the highest-volume regulated categories. FDA performance standards at 21 C.F.R. Part 1040 classify lasers into four hazard classes (Classes I through IV) based on accessible emission limits. Manufacturers of laser pointers, optical disc drives, laser printers, and surgical laser systems must certify to the applicable class limits and affix required warning labels.
Microwave ovens are subject to performance standards under 21 C.F.R. Part 1030, which set a maximum microwave radiation emission limit of 5 milliwatts per square centimeter measured at 5 centimeters from the oven's external surface for any point in time after the oven has been sold to the end user.
Sunlamp products and ultraviolet lamps are regulated under 21 C.F.R. Part 1040, requiring specific labeling that includes recommended exposure schedules and warnings about eye protection.
Television receivers and cathode ray tubes were subject to longstanding X-ray emission standards, though enforcement focus has shifted as cathode ray tube technology has been largely displaced by flat-panel displays. The historical regulatory infrastructure, however, remains in force for any products still manufactured or imported in those categories.
Accidental radiation occurrences — incidents in which a product emits radiation in excess of its design specification — trigger a separate mandatory reporting obligation at 21 C.F.R. Part 1002, requiring manufacturers to submit detailed reports to CDRH.
For manufacturers navigating questions about whether a specific product triggers reporting obligations, the broader landscape of FDA Adverse Event Reporting provides procedural context applicable across product types.
Decision boundaries
The most operationally significant decision boundary separates products regulated exclusively under the EPRC framework from products that are simultaneously regulated as medical devices. A laser used in a consumer barcode scanner is governed only by EPRC performance standards. The same laser wavelength incorporated into a surgical device is subject to EPRC standards and must clear the appropriate medical device pathway — either FDA 510(k) Clearance or PMA — depending on its risk classification.
A second boundary separates FDA jurisdiction from that of the Federal Communications Commission (FCC). The FCC regulates radio frequency (RF) emissions from telecommunications devices under the Communications Act of 1934 and its implementing rules at 47 C.F.R. Part 15. FDA and the FCC have maintained a formal Memorandum of Understanding to coordinate oversight of RF-emitting products. Under this arrangement, the FCC holds primary authority over RF interference and emission limits for communications equipment, while FDA retains authority over radiation safety for electronic products under the FD&C Act — including specific authority over the safety of RF emissions from cell phones as they relate to human health.
A third boundary exists between EPRC performance standards and Nuclear Regulatory Commission (NRC) jurisdiction. The NRC regulates radioactive materials and nuclear byproduct material under the Atomic Energy Act. FDA's EPRC authority covers radiation generated electronically — that is, by energizing a device — not radiation emitted by radioactive isotopes, which falls under NRC or Agreement State authority.
The FDA home page at /index provides entry-level navigation into all of FDA's regulatory programs, including the CDRH program page for radiation-emitting products. For practitioners assessing where a novel product falls within FDA's overall jurisdictional map, Key Dimensions and Scopes of FDA offers a structured framework for making that determination.